LogicBio Therapeutics LOGC 深 沪
等待开盘 09-20 09:30:00 美东时间
5.40
+0.030
+0.56%
华盛通- 最 高5.5233
- 今 开5.46
- 成交量 12.68万股
- 最 低 5.385
- 昨 收 5.37
- 总市值 1.78亿
- 52周最高 62.10
- 市盈率 静 --
- 换手率 0.00%
- 52周最低 4.92
- 委 比 -36.95%
- 总股本 3296.27万
- 历史最高 602.13
- 量 比 0.57
- 振 幅 2.58%
- 历史最低 4.92
- 每 手 1
- 风险率 0.24%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ContextLogic GAAP EPS of -$0.50
ContextLogic press release (NASDAQ:LOGC): Q2 GAAP EPS of -$0.50. As of June 30, 2024, the Company had $103 million in cash and cash equivalents, $47 million in marketable securities and $9 million in ...
08-09 05:48
ContextLogic Q2 2024 Adj EPS $(0.50) Misses $(0.06) Estimate, Sales $7.00M Beat $1.74M Estimate
ContextLogic (NASDAQ:LOGC) reported quarterly losses of $(0.50) per share which missed the analyst consensus estimate of $(0.06) by 733.33 percent. The company reported quarterly sales of $7.00 million which beat the
08-09 05:41
ContextLogic Enhances Leadership and Streamlines Governance
ContextLogic (LOGC) just unveiled an update. The Company has rewarded its CEO, ...
08-09 04:52
11 Consumer Discretionary Stocks Moving In Thursday's Intraday Session
Gainers JX Luxventure (NASDAQ:JXJT) shares increased by 13.3% to $1.7 during T...
07-05 00:31
KBR Awarded Global Contingency Services Multiple Award Contract with U.S. Navy
HOUSTON, May 6, 2024 /PRNewswire/ -- KBR (NYSE: KBR) announced today it has been awarded a multiple award, Indefinite Delivery Indefinite Quantity (IDIQ) contract by the U.S. Naval Facilitie...
05-06 18:00
KBR Announces First Quarter Fiscal 2024 Financial Results
Strong Q1 2024 Performance Adjusted EBITDA2 Growth with Margin Expansion HOUSTON, April 30, 2024 /PRNewswire/ -- KBR, Inc. (NYSE: KBR) today announced its first quarter fiscal 2024 financial...
04-30 18:55
KBR Secures $771M In LOGCAP Contract Options To Offer Logistics And Life Support Services To US Army EUCOM And NORTHCOM
LOGCAP is an indefinite delivery indefinite quantity contract with combatant command (COCOM) based task orders. The option period 4 performance is March 2024 to March 2025. Under the terms of the
04-30 04:32
BioMarin Announces Governance Enhancements and Value Creation Initiatives
Board Approves Appointment of Three New Independent Directors Company Establishes Strategic and Operating Review Committee of the Board BioMarin Enters into Cooperation and Information Shari...
2023-12-21 05:05
北海康成（1228.HK）在第 30 届欧洲基因与细胞治疗学会年会发表法布雷病基因治疗摘要
中国北京，美国马萨诸塞州剑桥，2023年10月25日— 北海康成制药有限公司（以下简称“北海康成”，股票代码“1228.HK”），是一家...
2023-10-25 18:36
KBR Successfully Settles Legacy Legal Matter
HOUSTON, July 3, 2023 /PRNewswire/ -- KBR (NYSE: KBR) announced today that it has settled a legacy lawsuit pending in federal court, USA ex rel Howard v. KBR, Inc. et al. "We are pleased to ...
2023-07-04 04:30
